← Open Payments lookup

ALEXANDER JACOBSON: Open Payments

NPI 1639199169 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$850 in 26 payments from 10 companies in 2025. Trend: 2023 $618 · 2024 $733 · 2025 $850

Food & beverage: $850
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$239
Janssen Pharmaceuticals, Inc3$156
E.R. Squibb & Sons, L.L.C.3$114
Axsome Therapeutics, Inc.4$93
Lundbeck LLC3$70
Indivior Inc.1$61
Alkermes, Inc.3$48
Teva Pharmaceuticals USA, Inc.1$32
Vanda Pharmaceuticals Inc.1$19
Neurocrine BioSciences, Inc.1$17

Products named: CAPLYTA, INVEGA SUSTENNA, COBENFY, Auvelity, REXULTI, SUBLOCADE, ARISTADA, UZEDY.

Industry payments across DE — which companies pay providers there.